title: Reply: To PMID 25110227.
authors.affiliation: Vancouver, BC, Canada.
authors.forename: Ramesh
authors.initials: R
authors.lastname: Saeedi
authors.affiliation: Vancouver, BC, Canada.
authors.forename: Min
authors.initials: M
authors.lastname: Li
authors.affiliation: Vancouver, BC, Canada.
authors.forename: Simon
authors.initials: S
authors.lastname: Rankin
authors.affiliation: Vancouver, BC, Canada.
authors.forename: Jiri
authors.initials: J
authors.lastname: Frohlich
mesh_terms: D015415:Biomarkers / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000175:diagnosis*; D005260:Female; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D017270:Lipoprotein(a) / Q000378:metabolism*; D009203:Myocardial Infarction / Q000175:diagnosis*; D009525:Niacin / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*
chemical_list: D015415:Biomarkers; D006538:Heptanoic Acids; D000960:Hypolipidemic Agents; D017270:Lipoprotein(a); D011758:Pyrroles; D009525:Niacin